| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
219,205 |
210,319 |
$27.81M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
456,204 |
408,601 |
$25.84M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
39,805 |
38,508 |
$16.99M |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
4,376 |
4,354 |
$11.61M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
52,315 |
51,143 |
$11.51M |
| G0378 |
Hospital observation service, per hour |
20,848 |
20,269 |
$10.12M |
| 41899 |
Unlisted procedure, dentoalveolar structures |
3,666 |
3,649 |
$4.05M |
| Q5103 |
Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg |
2,571 |
2,443 |
$2.83M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
10,570 |
10,279 |
$2.76M |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
8,581 |
8,306 |
$2.15M |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
43,105 |
11,697 |
$1.92M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
22,054 |
21,847 |
$1.90M |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
31,815 |
31,289 |
$1.83M |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
3,723 |
3,695 |
$1.73M |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
3,415 |
3,405 |
$1.73M |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
4,293 |
4,267 |
$1.69M |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
39,810 |
10,505 |
$1.61M |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
4,035 |
4,013 |
$1.56M |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
25,367 |
24,769 |
$1.55M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
24,189 |
23,636 |
$1.49M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
22,201 |
22,107 |
$1.37M |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
7,822 |
7,775 |
$1.29M |
| 42830 |
|
877 |
871 |
$1.24M |
| 92587 |
|
8,546 |
8,480 |
$1.21M |
| 54161 |
|
1,742 |
1,736 |
$1.15M |
| 95782 |
|
2,293 |
2,281 |
$1.13M |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
6,824 |
5,679 |
$1.11M |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
1,282 |
1,261 |
$1.11M |
| G0379 |
Direct admission of patient for hospital observation care |
1,890 |
1,877 |
$1.11M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
14,564 |
13,910 |
$914K |
| 76770 |
|
11,688 |
11,623 |
$912K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
28,204 |
8,442 |
$911K |
| 36455 |
|
4,449 |
3,849 |
$908K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
9,355 |
7,152 |
$901K |
| 71046 |
Radiologic examination, chest; 2 views |
28,464 |
27,836 |
$878K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
5,172 |
3,982 |
$851K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
13,287 |
13,246 |
$801K |
| 36430 |
|
3,882 |
2,936 |
$796K |
| 67311 |
|
701 |
687 |
$765K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
17,525 |
17,090 |
$738K |
| 95716 |
|
1,253 |
1,240 |
$675K |
| 70543 |
|
623 |
615 |
$669K |
| 95951 |
|
1,539 |
1,505 |
$667K |
| J1561 |
Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg |
552 |
459 |
$637K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
12,065 |
11,751 |
$633K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
7,512 |
7,405 |
$601K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
34,114 |
33,947 |
$565K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
14,668 |
11,718 |
$519K |
| J7050 |
Infusion, normal saline solution, 250 cc |
11,846 |
9,704 |
$518K |
| 95816 |
|
3,982 |
3,971 |
$509K |
| 54640 |
|
327 |
326 |
$498K |
| 92523 |
|
4,419 |
4,364 |
$490K |
| 95715 |
|
1,654 |
1,626 |
$462K |
| 76825 |
|
1,579 |
1,514 |
$456K |
| 93975 |
|
4,688 |
4,609 |
$437K |
| 64642 |
|
871 |
852 |
$418K |
| 95700 |
|
3,635 |
3,613 |
$418K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
41,283 |
40,833 |
$413K |
| 36591 |
|
2,188 |
1,522 |
$411K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
3,607 |
2,830 |
$409K |
| 92526 |
|
8,736 |
2,816 |
$396K |
| 96409 |
|
3,297 |
1,790 |
$392K |
| 67312 |
|
212 |
212 |
$380K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
6,471 |
6,423 |
$354K |
| Q5104 |
Injection, infliximab-abda, biosimilar, (renflexis), 10 mg |
404 |
371 |
$350K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
703 |
700 |
$337K |
| 31575 |
|
2,462 |
2,448 |
$316K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
15,615 |
14,672 |
$314K |
| 29075 |
|
1,753 |
1,692 |
$313K |
| 72197 |
|
372 |
369 |
$312K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
4,328 |
4,295 |
$281K |
| 70450 |
Computed tomography, head or brain; without contrast material |
5,177 |
5,118 |
$269K |
| 99381 |
|
4,007 |
3,980 |
$255K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
6,742 |
6,674 |
$254K |
| 97116 |
|
9,105 |
3,208 |
$251K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
9,845 |
9,688 |
$239K |
| 16020 |
|
4,113 |
2,759 |
$229K |
| 44970 |
|
84 |
82 |
$228K |
| 97760 |
|
4,692 |
2,319 |
$219K |
| 90670 |
|
16,095 |
14,656 |
$214K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
10,488 |
7,810 |
$210K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
315 |
312 |
$209K |
| J1459 |
Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg |
324 |
129 |
$201K |
| 99218 |
|
393 |
290 |
$198K |
| 54150 |
|
175 |
174 |
$193K |
| 29065 |
|
1,046 |
990 |
$192K |
| 72141 |
|
542 |
540 |
$189K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
114,950 |
100,548 |
$187K |
| 54360 |
|
111 |
111 |
$186K |
| 49500 |
|
105 |
105 |
$184K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
20,378 |
20,169 |
$180K |
| V5264 |
Ear mold/insert, not disposable, any type |
4,301 |
2,718 |
$171K |
| 97163 |
|
3,320 |
3,301 |
$168K |
| 42821 |
|
104 |
104 |
$162K |
| 71045 |
Radiologic examination, chest; single view |
5,756 |
5,576 |
$161K |
| 72156 |
|
81 |
81 |
$157K |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
86 |
80 |
$148K |
| 54163 |
|
145 |
143 |
$144K |
| 70486 |
|
1,720 |
1,713 |
$139K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
4,035 |
1,717 |
$139K |
| 96415 |
|
3,622 |
3,166 |
$137K |
| 92551 |
|
19,156 |
19,107 |
$130K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
3,141 |
2,187 |
$128K |
| 82728 |
|
25,695 |
23,776 |
$117K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
24,871 |
22,871 |
$107K |
| 97167 |
|
2,057 |
2,047 |
$106K |
| 29515 |
|
1,438 |
1,388 |
$92K |
| 92588 |
|
882 |
857 |
$92K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
9,822 |
9,605 |
$91K |
| 74183 |
|
559 |
554 |
$90K |
| 90378 |
|
68 |
65 |
$89K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
6,500 |
5,637 |
$86K |
| 90651 |
|
3,425 |
3,041 |
$85K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
642 |
615 |
$84K |
| 80053 |
Comprehensive metabolic panel |
34,810 |
33,532 |
$84K |
| 86902 |
|
4,294 |
3,720 |
$84K |
| 83655 |
|
13,640 |
13,550 |
$83K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
34,964 |
29,732 |
$79K |
| 36416 |
|
15,578 |
15,107 |
$77K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
9,798 |
9,589 |
$76K |
| 87631 |
|
17,917 |
17,625 |
$76K |
| 84443 |
Thyroid stimulating hormone (TSH) |
18,082 |
17,800 |
$76K |
| 94010 |
|
9,993 |
9,866 |
$75K |
| 20680 |
|
52 |
50 |
$72K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
3,220 |
3,167 |
$71K |
| 76536 |
|
3,070 |
3,016 |
$71K |
| 69210 |
|
2,782 |
2,754 |
$70K |
| 96450 |
|
501 |
386 |
$70K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
1,314 |
1,040 |
$68K |
| 17110 |
|
74 |
73 |
$67K |
| P9011 |
Blood, split unit |
948 |
879 |
$67K |
| 95117 |
|
3,219 |
1,766 |
$66K |
| 29105 |
|
1,008 |
973 |
$64K |
| 25605 |
|
71 |
71 |
$64K |
| J1756 |
Injection, iron sucrose, 1 mg |
777 |
563 |
$63K |
| 83735 |
|
28,615 |
22,071 |
$61K |
| 88184 |
|
708 |
673 |
$61K |
| 51784 |
|
881 |
876 |
$60K |
| 90474 |
|
10,396 |
10,361 |
$59K |
| 92585 |
|
671 |
635 |
$59K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
33,005 |
32,032 |
$58K |
| 92579 |
|
8,943 |
8,898 |
$58K |
| 86900 |
|
15,670 |
12,915 |
$58K |
| 80061 |
Lipid panel |
6,023 |
5,961 |
$55K |
| 74455 |
|
467 |
456 |
$54K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
2,445 |
2,391 |
$52K |
| 85046 |
|
41,717 |
31,848 |
$52K |
| 81003 |
|
32,746 |
31,598 |
$52K |
| G0008 |
Administration of influenza virus vaccine |
6,292 |
6,256 |
$50K |
| 92626 |
|
1,737 |
1,692 |
$50K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
13,520 |
13,431 |
$50K |
| 92557 |
|
5,187 |
5,163 |
$49K |
| 81025 |
|
23,720 |
22,813 |
$48K |
| 84460 |
|
38,216 |
32,293 |
$47K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
29,064 |
27,481 |
$47K |
| 84450 |
|
38,181 |
32,259 |
$46K |
| 90620 |
|
1,960 |
1,779 |
$44K |
| 74018 |
|
12,042 |
11,714 |
$43K |
| 10060 |
|
513 |
508 |
$41K |
| 84439 |
|
16,900 |
16,540 |
$41K |
| 92552 |
|
7,882 |
7,862 |
$39K |
| 97162 |
|
807 |
805 |
$39K |
| 51600 |
|
422 |
412 |
$38K |
| 93886 |
|
305 |
302 |
$38K |
| 92586 |
|
547 |
540 |
$38K |
| 82947 |
|
4,507 |
4,356 |
$37K |
| 77072 |
|
2,270 |
2,261 |
$37K |
| 90686 |
|
15,247 |
14,202 |
$37K |
| 97161 |
|
910 |
889 |
$36K |
| 82784 |
|
17,472 |
11,115 |
$36K |
| 72082 |
|
5,427 |
5,383 |
$36K |
| 96367 |
|
1,123 |
976 |
$35K |
| 29405 |
|
171 |
164 |
$35K |
| 86832 |
|
723 |
691 |
$34K |
| 82465 |
|
7,140 |
7,109 |
$34K |
| 86833 |
|
721 |
689 |
$34K |
| 36415 |
Collection of venous blood by venipuncture |
64,696 |
61,837 |
$34K |
| 86140 |
|
29,111 |
27,535 |
$34K |
| 92018 |
|
36 |
35 |
$33K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
5,023 |
5,001 |
$33K |
| A9270 |
Non-covered item or service |
181,407 |
146,914 |
$33K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
733 |
730 |
$33K |
| 12011 |
|
2,735 |
2,718 |
$32K |
| 87799 |
|
3,569 |
2,099 |
$32K |
| Q3014 |
Telehealth originating site facility fee |
2,338 |
2,229 |
$32K |
| 76506 |
|
992 |
982 |
$32K |
| G0009 |
Administration of pneumococcal vaccine |
4,193 |
4,170 |
$32K |
| 92595 |
|
1,069 |
1,066 |
$31K |
| 86780 |
|
4,258 |
4,234 |
$31K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
37,752 |
34,532 |
$31K |
| 83970 |
|
3,118 |
3,058 |
$30K |
| 97166 |
|
593 |
586 |
$30K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
10,842 |
10,341 |
$29K |
| 83718 |
|
6,496 |
6,482 |
$28K |
| 90716 |
|
4,172 |
3,849 |
$28K |
| 96411 |
|
774 |
475 |
$27K |
| 80051 |
|
24,667 |
23,555 |
$27K |
| 51741 |
|
506 |
505 |
$27K |
| 51798 |
|
4,634 |
4,470 |
$27K |
| 69200 |
|
841 |
819 |
$27K |
| 43762 |
|
220 |
206 |
$25K |
| 82565 |
|
23,266 |
21,661 |
$25K |
| 83550 |
|
11,163 |
10,495 |
$25K |
| 92567 |
|
31,499 |
31,109 |
$24K |
| 67808 |
|
24 |
24 |
$24K |
| 86850 |
|
15,296 |
12,538 |
$24K |
| J0475 |
Injection, baclofen, 10 mg |
49 |
48 |
$23K |
| 82805 |
|
14,677 |
14,261 |
$23K |
| 83021 |
|
6,081 |
5,550 |
$23K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
1,748 |
1,692 |
$22K |
| 82248 |
|
21,455 |
16,288 |
$22K |
| 82247 |
|
20,471 |
15,432 |
$22K |
| 83615 |
|
19,389 |
15,332 |
$22K |
| 90734 |
|
4,042 |
3,293 |
$22K |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
37 |
26 |
$22K |
| 73560 |
|
2,570 |
2,137 |
$21K |
| 84520 |
|
23,014 |
21,324 |
$20K |
| 92582 |
|
2,863 |
2,860 |
$20K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
7,289 |
6,509 |
$20K |
| 83540 |
|
11,786 |
11,070 |
$20K |
| 70260 |
|
2,873 |
2,866 |
$19K |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
284 |
272 |
$19K |
| 87496 |
|
2,445 |
1,848 |
$19K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
20,594 |
20,374 |
$19K |
| 84100 |
|
26,363 |
21,141 |
$19K |
| 76882 |
|
1,454 |
1,416 |
$19K |
| 92524 |
|
384 |
379 |
$19K |
| 73521 |
|
2,816 |
2,794 |
$18K |
| 82570 |
|
15,332 |
14,108 |
$18K |
| J1720 |
Injection, hydrocortisone sodium succinate, up to 100 mg |
957 |
748 |
$18K |
| 85027 |
|
6,302 |
6,213 |
$18K |
| 84075 |
|
17,847 |
13,691 |
$18K |
| 92652 |
|
191 |
186 |
$17K |
| 86923 |
|
3,773 |
3,202 |
$17K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
5,103 |
5,006 |
$17K |
| 94060 |
|
138 |
135 |
$16K |
| 83516 |
|
6,987 |
6,093 |
$16K |
| 86880 |
|
11,952 |
7,805 |
$16K |
| 74021 |
|
6,821 |
6,701 |
$15K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
21,742 |
21,382 |
$15K |
| 24640 |
|
167 |
165 |
$15K |
| 87536 |
|
353 |
331 |
$15K |
| 92610 |
|
331 |
327 |
$15K |
| 80069 |
|
2,629 |
1,939 |
$14K |
| 85652 |
|
15,767 |
15,069 |
$14K |
| 73130 |
|
5,083 |
4,572 |
$14K |
| 86360 |
|
1,249 |
1,213 |
$14K |
| 92019 |
|
15 |
15 |
$14K |
| 86803 |
|
2,352 |
2,324 |
$14K |
| 73630 |
|
6,630 |
5,886 |
$14K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
324 |
319 |
$13K |
| 73610 |
|
6,516 |
5,779 |
$13K |
| 12001 |
|
1,922 |
1,910 |
$13K |
| 76870 |
|
2,004 |
1,965 |
$13K |
| 81001 |
|
31,721 |
30,464 |
$13K |
| 95713 |
|
44 |
44 |
$12K |
| 62369 |
|
50 |
50 |
$12K |
| 93226 |
|
417 |
414 |
$12K |
| 76857 |
|
2,476 |
2,471 |
$12K |
| 86359 |
|
1,285 |
1,247 |
$12K |
| 84550 |
|
12,661 |
10,231 |
$12K |
| 92591 |
|
222 |
221 |
$11K |
| 73110 |
|
6,145 |
5,234 |
$11K |
| 83690 |
|
9,747 |
9,540 |
$11K |
| 83001 |
|
2,268 |
2,238 |
$11K |
| 83002 |
|
2,278 |
2,247 |
$11K |
| 74240 |
|
124 |
124 |
$11K |
| 90656 |
|
143 |
118 |
$11K |
| S0077 |
Injection, clindamycin phosphate, 300 mg |
1,876 |
1,232 |
$10K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
4,495 |
3,386 |
$10K |
| 74241 |
|
107 |
107 |
$10K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
3,245 |
3,180 |
$10K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
862 |
846 |
$10K |
| 80074 |
|
1,994 |
1,978 |
$10K |
| 93017 |
|
308 |
301 |
$10K |
| 84156 |
|
12,341 |
11,260 |
$10K |
| 73564 |
|
3,260 |
2,955 |
$10K |
| 87040 |
|
7,599 |
7,408 |
$10K |
| 82977 |
|
5,985 |
5,592 |
$10K |
| 80076 |
|
4,644 |
4,282 |
$9K |
| 80197 |
|
3,270 |
2,302 |
$9K |
| 72170 |
|
3,210 |
3,150 |
$9K |
| 73590 |
|
5,194 |
4,334 |
$9K |
| 85244 |
|
1,966 |
1,910 |
$9K |
| 85240 |
|
2,029 |
1,820 |
$9K |
| J7070 |
Infusion, d5w, 1000 cc |
3,598 |
3,213 |
$9K |
| 73090 |
|
7,283 |
5,435 |
$9K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
17,209 |
13,942 |
$9K |
| 82962 |
|
13,052 |
12,003 |
$9K |
| 86870 |
|
101 |
81 |
$9K |
| 86357 |
|
1,055 |
1,024 |
$9K |
| 82043 |
|
6,462 |
6,145 |
$9K |
| 86355 |
|
1,056 |
1,023 |
$9K |
| 85576 |
|
1,089 |
598 |
$9K |
| 82040 |
|
12,864 |
10,946 |
$9K |
| 64643 |
|
726 |
694 |
$8K |
| 86235 |
|
1,863 |
1,557 |
$8K |
| 83605 |
|
15,084 |
14,596 |
$8K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
5,818 |
5,774 |
$8K |
| 86038 |
|
2,954 |
2,919 |
$8K |
| 84703 |
|
6,613 |
5,938 |
$8K |
| 70360 |
|
1,994 |
1,969 |
$8K |
| 29345 |
|
55 |
46 |
$8K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
787 |
775 |
$8K |
| 31622 |
|
101 |
100 |
$8K |
| 85245 |
|
1,373 |
1,338 |
$8K |
| 82670 |
|
1,109 |
1,088 |
$8K |
| 86901 |
|
15,659 |
12,905 |
$8K |
| 93271 |
|
129 |
129 |
$8K |
| 86922 |
|
2,862 |
2,364 |
$8K |
| 93325 |
|
8,639 |
8,319 |
$7K |
| 73080 |
|
6,133 |
4,890 |
$7K |
| 70250 |
|
1,550 |
1,495 |
$7K |
| 82550 |
|
3,995 |
3,755 |
$7K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
19,613 |
18,524 |
$7K |
| 82330 |
|
15,346 |
14,872 |
$7K |
| 84403 |
|
1,158 |
1,140 |
$7K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
5,826 |
5,790 |
$7K |
| 86665 |
|
3,140 |
1,686 |
$7K |
| 85610 |
|
8,882 |
8,199 |
$7K |
| 86706 |
|
2,555 |
2,527 |
$7K |
| 86376 |
|
2,169 |
2,157 |
$7K |
| 85730 |
|
8,418 |
7,786 |
$7K |
| J7042 |
5% dextrose/normal saline (500 ml = 1 unit) |
15,509 |
13,101 |
$7K |
| 86480 |
|
450 |
441 |
$7K |
| 87077 |
|
5,711 |
5,359 |
$6K |
| 82533 |
|
1,473 |
1,420 |
$6K |
| 87081 |
|
5,182 |
5,121 |
$6K |
| 86341 |
|
1,120 |
722 |
$6K |
| 77073 |
|
1,998 |
1,982 |
$6K |
| 73140 |
|
3,957 |
3,510 |
$6K |
| 95714 |
|
162 |
162 |
$6K |
| 72146 |
|
210 |
210 |
$6K |
| 82310 |
|
6,399 |
6,114 |
$6K |
| 76885 |
|
137 |
137 |
$6K |
| 73552 |
|
2,676 |
2,351 |
$6K |
| 83880 |
|
1,028 |
911 |
$5K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
10,130 |
5,107 |
$5K |
| 72040 |
|
2,428 |
2,370 |
$5K |
| 76827 |
|
1,519 |
1,453 |
$5K |
| 82627 |
|
902 |
897 |
$5K |
| 74019 |
|
1,186 |
1,151 |
$5K |
| 86225 |
|
1,893 |
1,713 |
$5K |
| 86003 |
|
3,194 |
1,780 |
$5K |
| 83013 |
|
251 |
251 |
$5K |
| 82607 |
|
1,324 |
1,285 |
$5K |
| 72100 |
|
1,031 |
1,019 |
$5K |
| 82131 |
|
1,040 |
1,010 |
$5K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
30,129 |
29,380 |
$5K |
| 49452 |
|
16 |
14 |
$5K |
| 93320 |
|
8,407 |
8,107 |
$5K |
| 83020 |
|
1,943 |
1,681 |
$5K |
| 82785 |
|
1,443 |
1,415 |
$5K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
72 |
72 |
$5K |
| 86800 |
|
1,593 |
1,587 |
$5K |
| 82150 |
|
4,160 |
4,071 |
$5K |
| 73030 |
|
1,890 |
1,738 |
$5K |
| 99383 |
|
67 |
67 |
$5K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
39 |
39 |
$5K |
| 85384 |
|
1,997 |
1,865 |
$5K |
| 83993 |
|
615 |
606 |
$5K |
| 86364 |
|
1,582 |
1,577 |
$5K |
| 29705 |
|
44 |
42 |
$4K |
| 86769 |
|
259 |
256 |
$4K |
| 72158 |
|
78 |
78 |
$4K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
190 |
189 |
$4K |
| J2704 |
Injection, propofol, 10 mg |
32,012 |
31,140 |
$4K |
| 84145 |
|
709 |
681 |
$4K |
| 94664 |
|
1,987 |
1,982 |
$4K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
558 |
550 |
$4K |
| 29505 |
|
53 |
51 |
$4K |
| 84305 |
|
1,943 |
1,934 |
$4K |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
371 |
365 |
$4K |
| 92522 |
|
78 |
78 |
$4K |
| 95712 |
|
24 |
24 |
$4K |
| 92556 |
|
8,622 |
8,604 |
$4K |
| 86664 |
|
1,727 |
1,670 |
$4K |
| 86905 |
|
199 |
198 |
$3K |
| 84402 |
|
439 |
438 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
5,802 |
5,718 |
$3K |
| 86663 |
|
1,729 |
1,672 |
$3K |
| 73060 |
|
1,604 |
1,408 |
$3K |
| 73000 |
|
1,147 |
1,079 |
$3K |
| 86039 |
|
1,053 |
1,035 |
$3K |
| 87070 |
|
3,107 |
3,010 |
$3K |
| 83520 |
|
1,643 |
1,539 |
$3K |
| S0080 |
Injection, pentamidine isethionate, 300 mg |
834 |
785 |
$3K |
| 92555 |
|
8,748 |
8,712 |
$3K |
| 88342 |
|
1,052 |
1,029 |
$3K |
| 73562 |
|
1,157 |
1,058 |
$3K |
| P9040 |
Red blood cells, leukocytes reduced, irradiated, each unit |
15 |
12 |
$3K |
| 12002 |
|
366 |
366 |
$2K |
| 72157 |
|
40 |
40 |
$2K |
| 73120 |
|
794 |
711 |
$2K |
| 84478 |
|
767 |
707 |
$2K |
| 84484 |
|
2,281 |
2,189 |
$2K |
| 86147 |
|
522 |
397 |
$2K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
46 |
45 |
$2K |
| 29125 |
|
2,200 |
2,155 |
$2K |
| 30901 |
|
14 |
14 |
$2K |
| 92594 |
|
150 |
150 |
$2K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
136 |
136 |
$2K |
| 82340 |
|
1,805 |
1,760 |
$2K |
| 83037 |
|
1,146 |
1,138 |
$2K |
| 82274 |
|
500 |
475 |
$2K |
| 72070 |
|
220 |
219 |
$2K |
| C1769 |
Guide wire |
1,530 |
1,470 |
$2K |
| 94375 |
|
27 |
26 |
$2K |
| 88300 |
|
3,876 |
3,848 |
$2K |
| 85732 |
|
1,145 |
598 |
$2K |
| 95813 |
|
13 |
13 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
6,962 |
5,757 |
$2K |
| 94660 |
|
321 |
206 |
$2K |
| 86431 |
|
1,119 |
1,113 |
$2K |
| 83525 |
|
619 |
607 |
$2K |
| 87467 |
|
407 |
401 |
$2K |
| 77076 |
|
407 |
406 |
$2K |
| 84155 |
|
1,883 |
1,684 |
$2K |
| 87340 |
|
724 |
713 |
$2K |
| 84134 |
|
897 |
870 |
$2K |
| J1644 |
Injection, heparin sodium, per 1000 units |
3,128 |
1,224 |
$2K |
| 95822 |
|
12 |
12 |
$2K |
| 82652 |
|
358 |
354 |
$1K |
| 87807 |
|
3,123 |
3,044 |
$1K |
| 83930 |
|
919 |
822 |
$1K |
| 88185 |
|
348 |
329 |
$1K |
| 83498 |
|
421 |
417 |
$1K |
| 84146 |
|
236 |
235 |
$1K |
| 83921 |
|
364 |
339 |
$1K |
| 85250 |
|
227 |
224 |
$1K |
| 97165 |
|
29 |
29 |
$1K |
| 86337 |
|
194 |
192 |
$1K |
| 82803 |
|
789 |
739 |
$1K |
| 86317 |
|
336 |
222 |
$1K |
| 11900 |
|
13 |
13 |
$1K |
| 73620 |
|
678 |
583 |
$1K |
| 87046 |
|
907 |
883 |
$999.12 |
| 72081 |
|
806 |
797 |
$983.73 |
| 82746 |
|
246 |
242 |
$949.17 |
| 87045 |
|
887 |
869 |
$946.63 |
| 87205 |
|
2,233 |
2,169 |
$898.02 |
| 85379 |
|
780 |
724 |
$897.74 |
| 30300 |
|
55 |
52 |
$872.00 |
| 80230 |
|
91 |
81 |
$845.22 |
| 70480 |
|
12 |
12 |
$822.02 |
| 84702 |
|
318 |
309 |
$798.35 |
| 88312 |
|
437 |
437 |
$787.59 |
| 92650 |
|
485 |
485 |
$786.60 |
| 86255 |
|
282 |
273 |
$764.25 |
| 76642 |
|
40 |
38 |
$756.82 |
| 82105 |
|
162 |
159 |
$748.38 |
| 73100 |
|
580 |
452 |
$738.60 |
| 99152 |
|
322 |
320 |
$714.04 |
| J0290 |
Injection, ampicillin sodium, 500 mg |
798 |
605 |
$640.36 |
| 86709 |
|
213 |
210 |
$619.53 |
| J2997 |
Injection, alteplase recombinant, 1 mg |
13 |
12 |
$586.41 |
| J1953 |
Injection, levetiracetam, 10 mg |
276 |
250 |
$570.47 |
| 82010 |
|
818 |
696 |
$569.61 |
| 99156 |
|
243 |
241 |
$562.93 |
| 88304 |
|
1,979 |
1,958 |
$559.91 |
| 93243 |
|
39 |
39 |
$553.28 |
| 0001A |
|
25 |
21 |
$542.56 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
17,565 |
16,676 |
$537.77 |
| 90473 |
|
144 |
144 |
$529.11 |
| 85247 |
|
78 |
78 |
$528.60 |
| 83090 |
|
125 |
123 |
$527.25 |
| 73070 |
|
496 |
432 |
$524.06 |
| 82024 |
|
256 |
252 |
$514.04 |
| 62322 |
|
242 |
174 |
$498.79 |
| 80164 |
|
98 |
96 |
$496.87 |
| 96376 |
|
2,269 |
1,775 |
$488.00 |
| 84466 |
|
100 |
96 |
$486.68 |
| 82747 |
|
122 |
119 |
$480.40 |
| 82379 |
|
147 |
144 |
$471.33 |
| G0109 |
Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes |
12 |
12 |
$459.17 |
| 84481 |
|
155 |
151 |
$438.35 |
| 80165 |
|
25 |
25 |
$435.42 |
| 89230 |
|
25 |
25 |
$412.85 |
| 82542 |
|
1,616 |
1,541 |
$412.50 |
| 93225 |
|
51 |
51 |
$402.27 |
| 80195 |
|
81 |
51 |
$401.79 |
| 90732 |
|
13 |
13 |
$400.41 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
543 |
529 |
$377.56 |
| 82139 |
|
68 |
68 |
$350.85 |
| 90680 |
|
10,321 |
9,453 |
$348.78 |
| 82985 |
|
211 |
207 |
$343.51 |
| 89050 |
|
601 |
535 |
$338.57 |
| 80177 |
|
117 |
116 |
$320.58 |
| 99155 |
|
133 |
133 |
$306.58 |
| S5010 |
5% dextrose and 0.45% normal saline, 1000 ml |
1,568 |
1,244 |
$305.36 |
| 87480 |
|
65 |
65 |
$288.69 |
| 87510 |
|
65 |
65 |
$288.69 |
| 86308 |
|
826 |
819 |
$288.61 |
| 86704 |
|
86 |
85 |
$287.36 |
| 84202 |
|
70 |
69 |
$285.12 |
| 99151 |
|
123 |
122 |
$275.12 |
| 82610 |
|
1,513 |
1,498 |
$270.00 |
| 84480 |
|
98 |
93 |
$261.84 |
| 82017 |
|
112 |
107 |
$255.22 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
1,101 |
1,012 |
$252.07 |
| J9370 |
Vincristine sulfate, 1 mg |
2,043 |
1,304 |
$247.82 |
| 87493 |
|
56 |
55 |
$245.22 |
| V5011 |
Fitting/orientation/checking of hearing aid |
902 |
900 |
$222.22 |
| 73600 |
|
42 |
29 |
$222.09 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
3,955 |
3,913 |
$219.31 |
| 90744 |
|
56 |
51 |
$216.42 |
| 87209 |
|
134 |
129 |
$208.57 |
| 85014 |
|
684 |
635 |
$199.03 |
| 86787 |
|
54 |
50 |
$189.49 |
| 84132 |
|
687 |
608 |
$180.45 |
| 84295 |
|
650 |
579 |
$170.22 |
| 87660 |
|
37 |
37 |
$164.77 |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
428 |
274 |
$160.69 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,411 |
1,394 |
$146.85 |
| 82140 |
|
93 |
87 |
$132.66 |
| 88341 |
|
69 |
67 |
$129.46 |
| S0028 |
Injection, famotidine, 20 mg |
1,597 |
1,257 |
$128.49 |
| 86644 |
|
120 |
114 |
$123.40 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
2,602 |
2,449 |
$122.75 |
| 84681 |
|
147 |
144 |
$120.90 |
| 94680 |
|
135 |
129 |
$119.32 |
| 87338 |
|
16 |
16 |
$111.15 |
| 86200 |
|
68 |
68 |
$104.57 |
| 90633 |
|
8,265 |
7,708 |
$104.00 |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
427 |
423 |
$103.88 |
| 87177 |
|
134 |
129 |
$103.27 |
| 86146 |
|
25 |
24 |
$102.81 |
| 86701 |
|
196 |
195 |
$101.70 |
| J2916 |
Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg |
134 |
80 |
$92.88 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
1,128 |
1,090 |
$90.12 |
| 90647 |
|
10,611 |
9,838 |
$89.82 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
1,176 |
1,121 |
$89.79 |
| 84436 |
|
149 |
148 |
$87.62 |
| 73502 |
|
39 |
39 |
$86.98 |
| 90715 |
|
2,476 |
2,144 |
$85.97 |
| P9041 |
Infusion, albumin (human), 5%, 50 ml |
12 |
12 |
$75.39 |
| 85520 |
|
15 |
15 |
$71.78 |
| 88262 |
|
12 |
12 |
$70.91 |
| 94200 |
|
91 |
91 |
$69.66 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
1,860 |
1,833 |
$65.83 |
| 90723 |
|
10,688 |
10,049 |
$64.51 |
| 87529 |
|
99 |
55 |
$60.03 |
| 82157 |
|
27 |
27 |
$56.16 |
| 99157 |
|
28 |
28 |
$55.49 |
| 88275 |
|
12 |
12 |
$52.43 |
| 86765 |
|
42 |
39 |
$50.88 |
| 82438 |
|
38 |
37 |
$49.92 |
| 88271 |
|
12 |
12 |
$48.75 |
| 92558 |
|
266 |
264 |
$48.24 |
| 77075 |
|
12 |
12 |
$47.04 |
| 86645 |
|
82 |
80 |
$46.19 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
97 |
97 |
$44.78 |
| 90700 |
|
3,857 |
3,613 |
$44.52 |
| 83010 |
|
32 |
27 |
$40.88 |
| 73660 |
|
42 |
38 |
$40.35 |
| 90707 |
|
4,000 |
3,699 |
$38.85 |
| J0736 |
Injection, clindamycin phosphate, 300 mg |
80 |
54 |
$38.20 |
| 82180 |
|
14 |
14 |
$37.67 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
24,118 |
23,673 |
$35.79 |
| Q9968 |
Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg |
85 |
82 |
$33.21 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
24 |
24 |
$31.86 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
3,305 |
3,240 |
$28.72 |
| J2060 |
Injection, lorazepam, 2 mg |
384 |
255 |
$28.59 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
18 |
18 |
$24.60 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
4,946 |
4,856 |
$24.22 |
| 84244 |
|
12 |
12 |
$22.93 |
| 84157 |
|
28 |
26 |
$19.26 |
| 76376 |
|
346 |
346 |
$18.65 |
| 88280 |
|
12 |
12 |
$17.14 |
| 90696 |
|
3,258 |
2,970 |
$15.05 |
| 82390 |
|
12 |
12 |
$14.24 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
8,928 |
8,797 |
$13.29 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
15 |
15 |
$10.80 |
| 82945 |
|
28 |
26 |
$8.92 |
| 82085 |
|
25 |
25 |
$4.00 |
| J9260 |
Injection, methotrexate sodium, 50 mg |
738 |
394 |
$1.88 |
| 85018 |
|
14 |
14 |
$1.31 |
| S0030 |
Injection, metronidazole, 500 mg |
14 |
12 |
$1.27 |
| J1580 |
Injection, garamycin, gentamicin, up to 80 mg |
13 |
12 |
$0.72 |
| 85396 |
|
227 |
223 |
$0.00 |
| 90710 |
|
76 |
74 |
$0.00 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
323 |
322 |
$0.00 |
| A9576 |
Injection, gadoteridol, (prohance multipack), per ml |
3,511 |
3,393 |
$0.00 |
| 82272 |
|
12 |
12 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
150 |
117 |
$0.00 |
| J0692 |
Injection, cefepime hydrochloride, 500 mg |
30 |
12 |
$0.00 |
| 94799 |
|
52 |
35 |
$0.00 |
| J1240 |
Injection, dimenhydrinate, up to 50 mg |
141 |
140 |
$0.00 |
| 51701 |
|
58 |
58 |
$0.00 |
| 90713 |
|
95 |
81 |
$0.00 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
1,047 |
994 |
$0.00 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
22 |
12 |
$0.00 |
| 82397 |
|
19 |
17 |
$0.00 |
| Q9958 |
High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml |
58 |
58 |
$0.00 |
| J2004 |
Injection, lidocaine hcl with epinephrine, 1 mg |
75 |
75 |
$0.00 |
| 88313 |
|
30 |
25 |
$0.00 |
| A4565 |
Slings |
14 |
14 |
$0.00 |
| 76377 |
|
146 |
145 |
$0.00 |
| C1766 |
Introducer/sheath, guiding, intracardiac electrophysiological, steerable, other than peel-away |
689 |
612 |
$0.00 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
207 |
206 |
$0.00 |
| 94760 |
|
308 |
302 |
$0.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
77 |
65 |
$0.00 |
| 87181 |
|
38 |
27 |
$0.00 |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
14 |
12 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
448 |
445 |
$0.00 |
| 86258 |
|
20 |
12 |
$0.00 |
| 86353 |
|
12 |
12 |
$0.00 |
| 88307 |
|
28 |
28 |
$0.00 |
| 87425 |
|
21 |
20 |
$0.00 |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
49 |
49 |
$0.00 |
| 29130 |
|
13 |
12 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
13 |
13 |
$0.00 |